Skip to content
healthcare.dev

Eslicarbazepine Acetate

NDC 59746-717, eslicarbazepine acetate, tablet, from Jubilant Cadista Pharmaceuticals Inc..

Product NDC
59746-717
Status
Listed
Labeler
Jubilant Cadista Pharmaceuticals Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211219
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59746-717 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ESLICARBAZEPINE ACETATE200 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
59746-717-10597460717101000 TABLET in 1 BOTTLE (59746-717-10)
59746-717-305974607173030 TABLET in 1 BOTTLE (59746-717-30)
59746-717-905974607179090 TABLET in 1 BOTTLE (59746-717-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/22d08671-ac0d-4e3d-8195-929bbb021125
  • NADAC price for package 59746071730

    GET /v1/drugs/nadac/59746071730

Use it

Look up 59746-717 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59746-717 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59746-717. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.